UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor

Oncogene, 2022-05, Vol.41 (20), p.2824-2832

2022

Volltextzugriff (PDF)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

The Journal of clinical investigation, 2022-12, Vol.132 (23)

2022

Volltextzugriff (PDF)

The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells

PloS one, 2012-12, Vol.7 (12), p.e52106-e52106

2012

Volltextzugriff (PDF)

Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens

PloS one, 2023-10, Vol.18 (10), p.e0287126-e0287126

2023

Volltextzugriff (PDF)

Accurate and Early Metastases Diagnosis in Live Animals With Multimodal X-ray and Optical Imaging

International journal of radiation oncology, biology, physics, 2023-02, Vol.115 (2), p.511-517

2023

Volltextzugriff (PDF)

Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (44), p.11298-11303

2018

Volltextzugriff (PDF)

Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans

Molecular cancer research, 2022-08, Vol.20 (8), p.1295-1304

2022

Volltextzugriff (PDF)

Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Science translational medicine, 2019-06, Vol.11 (498)

2019

Volltextzugriff (PDF)

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer

Nature communications, 2017-10, Vol.8 (1), p.1204-13, Article 1204

2017

Volltextzugriff (PDF)

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

European urology, 2018-05, Vol.73 (5), p.715-723

2018

Volltextzugriff (PDF)

Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer

Molecular systems biology, 2018-08, Vol.14 (8), p.e8202-n/a

2018

Volltextzugriff (PDF)

International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors

Pharmacological reviews, 2006-12, Vol.58 (4), p.782-797

2006

Volltextzugriff (PDF)

Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy

Journal of cellular biochemistry, 2005-07, Vol.95 (4), p.657-669

Burnstein, Kerry L.

2005

Volltextzugriff (PDF)

Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival

Molecular endocrinology (Baltimore, Md.), 2012-12, Vol.26 (12), p.1967-1979

2012

Volltextzugriff (PDF)

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (3), p.1084-1089

2014

Volltextzugriff (PDF)

Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth Inhibition

Endocrinology (Philadelphia), 2010-03, Vol.151 (3), p.896-908

2010

Volltextzugriff (PDF)

Inhibition of Androgen Receptor Transcriptional Activity as a Novel Mechanism of Action of Arsenic

Molecular endocrinology (Baltimore, Md.), 2009-03, Vol.23 (3), p.412-421

2009

Volltextzugriff (PDF)

Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis

Oncogene, 2019-02, Vol.38 (6), p.838-851

2019

Volltextzugriff (PDF)

Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity

Molecular cancer therapeutics, 2016-06, Vol.15 (6), p.1353-1363

2016

Volltextzugriff (PDF)

Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer

iScience, 2023-09, Vol.26 (9), p.107681-107681, Article 107681

2023

Volltextzugriff (PDF)

GADD45γ: a New Vitamin D-Regulated Gene that Is Antiproliferative in Prostate Cancer Cells

Endocrinology (Philadelphia), 2010-10, Vol.151 (10), p.4654-4664

2010

Volltextzugriff (PDF)

Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts

Molecular cancer therapeutics, 2013-04, Vol.12 (4), p.394-404

2013

Volltextzugriff (PDF)

Novel Interaction between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth

The Journal of biological chemistry, 2013-02, Vol.288 (8), p.5463-5474

2013

Volltextzugriff (PDF)

Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells

Molecular endocrinology (Baltimore, Md.), 2014-06, Vol.28 (6), p.872-885

2014

Volltextzugriff (PDF)

Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities

Molecular cancer research, 2017-11, Vol.15 (11), p.1469-1480

2017

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(97)
Dissertationen
(1)

Sprache

Englisch
(98)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Humans
(54)
Life Sciences & Biomedicine
(52)
Male
(41)
Cell Line, Tumor
(26)
Animals
(24)
Prostate Cancer
(21)
Biological And Medical Sciences
(20)
Endocrinology & Metabolism
(20)
Oncology
(19)
Receptors, Androgen - Metabolism
(18)
Biochemistry & Molecular Biology
(16)
Prostatic Neoplasms - Pathology
(16)
Androgens
(15)
Prostatic Neoplasms - Genetics
(15)
Cell Proliferation
(14)
Receptors, Androgen - Genetics
(14)
Cell Biology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Prostatic Neoplasms - Metabolism
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells

Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens

Accurate and Early Metastases Diagnosis in Live Animals With Multimodal X-ray and Optical Imaging

Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth

Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans

Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer

International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors

Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy

Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer

Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth Inhibition

Inhibition of Androgen Receptor Transcriptional Activity as a Novel Mechanism of Action of Arsenic

Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis

Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity

Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancer

GADD45γ: a New Vitamin D-Regulated Gene that Is Antiproliferative in Prostate Cancer Cells

Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts

Novel Interaction between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth

Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells

Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities

Suchergebnisse filtern